α1-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation

American Journal of Physiology - Heart and Circulatory Physiology - Tập 283 Số 4 - Trang H1471-H1480 - 2002
Geir Øystein Andersen1,2,3, Eirik Qvigstad2, Iwona Schiander2, Halfdan Aass4, Jan-Bjørn Osnes2, Tor Skomedal2
1Department of Internal Medicine, Ullerål University Hospital, University of Oslo, N-0316 Oslo, Norway
2Department of Pharmacology
3Merck Sharp & Dohme Cardiovascular Research Center, and
4Department of Cardiology, Rikshospitalet University Hospital,

Tóm tắt

The possible involvement of different kinases in the α1-adrenoreceptor (AR)-mediated positive inotropic effect (PIE) was investigated in rat papillary muscle and compared with β-AR-, endothelin receptor- and phorbol ester-induced changes in contractility. The α1-AR-induced PIE was not reduced by the inhibitors of protein kinase C (PKC), MAPK (ERK and p38), phosphatidyl inositol 3-kinase, or calmodulin kinase II. However, PKC inhibition attenuated the effect of phorbol 12-myristate 13-acetate (PMA) on contractility. α1-AR-induced PIE was reduced by ∼90% during inhibition of myosin light chain kinase (MLCK) by 1-(5-chloronaphthalene-1-sulfonyl)1 H-hexahydro-1,4-diazepine (ML-9). Endothelin-induced PIE was also reduced by ML-9, but ML-9 had no effect on β-AR-induced PIE. The Rho kinase inhibitor Y-27632 also reduced the α1-AR-induced PIE. The α1-AR-induced PIE in muscle strips from explanted failing human hearts was also sensitive to MLCK inhibition. α1-AR induced a modest increase in32P incorporation into myosin light chain in isolated rat cardiomyocytes. This effect was eliminated by ML-9. The PIE of α1-AR stimulation seems to be dependent on MLCK phosphorylation.

Từ khóa


Tài liệu tham khảo

10.1152/ajpheart.1998.275.2.H641

10.1038/72287

Blinks JR, 1986, Circulation, 73, III85

10.1042/bj3140115

10.1016/S0022-2828(08)80060-0

Brodde OE, 1999, Pharmacol Rev, 51, 651

10.1042/bj2850311

10.1152/ajpheart.1997.273.3.H1113

Deng XF, 1998, J Pharmacol Exp Ther, 286, 489

10.1016/0167-5273(93)90001-W

10.1152/ajpheart.1991.260.1.H27

10.1152/physrev.1993.73.2.469

10.1016/S1071-9164(96)80058-3

10.1161/01.RES.71.4.870

Knepper SM, 1995, J Pharmacol Exp Ther, 274, 97

10.1016/S0024-3205(96)00650-9

10.1007/s001099900031

10.1111/j.1600-0773.1978.tb02195.x

10.1016/S0140-6736(05)74182-9

10.1161/01.RES.67.2.517

10.1016/0165-6147(92)90080-P

10.1007/BF00227882

10.1007/BF00969089

10.1016/0143-4160(81)90049-X

10.1111/j.1469-7793.1997.217bc.x

10.1152/ajpheart.1999.276.5.H1655

10.1016/S0008-6363(99)00144-3

Skomedal T, 1997, J Pharmacol Exp Ther, 280, 721

10.1111/j.1600-0773.1983.tb01076.x

10.1038/372231a0

10.1016/0006-291X(91)92031-E

10.1113/jphysiol.1992.sp019002

Terzic A, 1993, Pharmacol Rev, 42, 147

10.1038/40187

Venema RC, 1993, J Biol Chem, 268, 2705, 10.1016/S0021-9258(18)53831-X

10.1042/bj2940401

10.1111/j.1600-0773.1995.tb00105.x

Thông tin
Thông tin xuất bản

American Journal of Physiology - Heart and Circulatory Physiology

Tập 283 Số 4

H1471-H1480

Thông tin tác giả